fungus Asperflus, and certain drugs are particular agents associated with the development of eosinophilic pneumonia. Laeffler's syndrome in particular has been reported secondary to various drugs. Isolated case reports of this syndrome are found in the literature to nicke1,s penicillin,' PAS,5 chlorpropamide,e imipramine,? aurothioglucose (Solganal)? and ~ulfonamides.~ Klinghoffen,lo in 1954, reported a case of Loeffler's syndrome following the use of a sulfonamidecontaining vaginal cream.
Our patient developed allergic symptoms shortly after using a similar vaginal cream, containing sulfanilamide (15 percent), aminacrine (0.2 percent) and allantoin (2.0 percent), with lactose in a water miscible base. Her symptoms subsided dramatically after the cessation of its use, and the pulmonary infiltrates and blood eosinophilia also completely resolved. The patient was not rechallenged because it was felt that the association between the use of the vaginal cream and the subsequent development of symptoms, pulmonary infiltrations, and blood eosinophilia, and their cessation following the discontinuation of the cream, was real, and not related to chance. This case again points. out the importance of a complete drug history in patients with peripheral eosinophilia and pulmonary infiltrates. S ince the observations of Laurell and ErikssonlJ in the mid 1960's, and subsequently by numerous other group^,^-^ the association of alpha,-antitrypsin deficiency with pulmonary emphysema has become well known. More recently an association of this deficiency with cirrhosis, both infantile and adult,T-9 has been established.
We have recently treated a patient with &e, severe bronchiectasis associated with hornozygous alpha,-antitrypsin deficiency.
A 34-year-old woman of British descent presented in 1973 complaining of increased sputum production, fever and nausea. She had pertussis at age two but experienced no respiratory symptoms until 1963 when she had the onset of nocturnal pleuritic chest pain and a nonproductive cough. Two months thereafter she developed the first of several episodes of fever associated with productive cough and lower lobe infiltrates. In 1964, bronchography revealed severe cystic bronchiectasis involving the entire bronchial tree bilaterally (Fig 1) . Between 1965 and 1973, she suffered numerous episodes of increased bronchial infection, hemoptysis, consolidation of various lobes and purulent sputum production to 400 ml a day. Since 1968, she had experienced a progressive increase in exertional dyspnea.
She smoked less than one-half pack of cigarettes a day intermittently between 1959 and 1970. Family history revealed that one maternal uncle and two maternal aunts, all cigarette smokers, had emphysema or bronchitis. There was no family history of bronchiectasis, cystic fibrosis or liver disease.
Examination revealed her to be febrile and to appear chronically ill, weighing 49 kg. Diffuse bronchial breath sounds and coarse inspiratory rales over the lower half of her FIGURE 1. Bronchogram (1964) .
234 LONGSTRETH ET A1 chest were heard. Her fingers were clubbed without nail cyanosis. The remainder of the examination was normal. Chest roentgenogram revealed diffuse pulmonary scarring' with numerous cavities, typical of bronchiectasis ( Fig 2) . Serum electrophoresis revealed decreased alpha1 globulin (0.1 g per 100 ml). The al-antitrypsin concentration was less than 50 mg per 100 ml (normal 200 mg). Characterization revealed a Pi ZZ phenotype and a serum t q p sin inhibitory capacity of 0.215 units (normal >0.85 units). Sweat sodium content was 60 mEq per liter. Aerobic sputum cultures revealed throat flora. Results of immunoglobulin assays, urinalysis, hemoglobin, leukocyte count, blood urea nitrogen, fasting blood sugar, alkaline phosphatase, bilirubin, serum glutarnic oxaloacetic transaminase, tuberculin skin test and electrocardiogram were normal.
The patient was subjected to bronchoscopy which revealed numerous pus-filled, cystic cavities; 200 ml of purulent material was aspirated. Generalized cystic bronchiectasis is an uncommon disease. It is not generally thought to be part of the spectrum of, nor secondary to, chronic obstructive lung disease.lo-l1 The diseases which most commonly lead to secondary, severe bronchiectasis include mucoviscidosis, immunoglobulin deficiencies, pertussis, influenza, measles and other viral pneumonias, aspiration, and recurrent bacterial pneumonias. There is also a well-known association with sinusitis and/or dextrocardia. The occurrence of bronchiectasis in our patient with homozygous a,-antitrypsin deficiency prompted us to review the association between these two entities.
Upon examination it appears that the relationship between alphal-antitrypsin deficiency and generalized bronchiectasis is well documented but has received minimal a t t e n t i~n .~-~ Indeed two of Eriksson's original 23 patients had clinically severe, diffuse bronchiectasis as a prominent part of their illness.2 As noted by Falk and Smith,l2 the classic description of a smoker developing severe, "dry," panacinar emphysema in the third or fourth decade is too restrictive. In a comparison of a large group of patients with severe pulmonary emphysema, Hutchinson and associatess found chronic bronchitis in 62 percent of those with homozygous deficiency versus 70 percent of those with no deficiency-an insignificant difference. Bronchiectasis, although much less common, appears to represent another portion of the spectrum of pulmonary complications found with this deficiency. We want to emphasize that, in our patient, dinical and roentgenographic manifestations of severe bronchiectasis (copious, purulent sputum production and hemoptysis, recurrent pulmonary infection, and multiple cystic cavities with air-fluid levels) were the dominant features of her illness for several years prior to the onset of dyspnea and still represent the most difficult management problems.
The pathogenesis of bronchiectasis in this setting has not been completely resolved. As summarized by Lieberman,18 much of the current thinking regarding the development of pulmonary disease in these patients revolves around the knowledge that alphal-antitrypsin inhibits a multitude of proteolytic enzymes, such as trypsin, elastase, bacterial and leukocyte proteases, chyrnotrypsin, and possibly many others. It is postulated that the protease inhibitory capability of human serum protects the lung from injury, especially during periods of inflammation or infection, when there are likely to be high local concentrations of proteases. If this protective capacity is deficient, the pulmonary parenchyma becomes more susceptible to destruction.
In light of this hypothesis, the histopathologic observations of Glasgow et a18 are very intriguing. They noted, in their one necropsy specimen, diffuse bronchial and bronchiolar dilatation as well as panacinar emphysema. The elastic lamina was not intact in any of the bronchi examined and was totally absent from the walls of many of the specially stained specimens. It is certainly attractive to postulate a similar mechanism operative in our patient, who had pertussis in childhood. That is, in the presence of underlying, alphal-antitrypsin deficiency, a childhood infection led to destruction of bronchial walls and subsequent bronchiectasis.
We cannot be absolutely sure our patient's enzyme inhibitor deficiency caused her bronchiectasis. However; the rarity of these two conditions separately and the previously reported occurrence of the two entities together, strongly point to an association between them. Since most patients with bronchiectasis are probably not screened for the enzyme inhibitor deficiency, the frequency of its presence in such patients is unknown. Alphal-antitrypsin levels should be measured in patients with severe bronchiectasis. 54: 181-194, 1973 
